Table 2.
Tumor p-NDRG1 (DAB/nuclear area %) and blood PSA levels in PCa patients that were successfully treated following prostatectomy (Remission; n = 18) versus those that relapsed with metastases (Relapsed; n = 13)
| Patient sample group | p-NDRG1Ser330 |
Average DAB staining (%) | IHC significance compared with Remission | PSA levels | Significance (p-value) of NDRG1 and PSA correlation | |
|---|---|---|---|---|---|---|
| Negative | Positive | |||||
| Remission | 6 | 12 | 19.11 ± 4.11 | --- | 7.41 ± 0.59 | 0.8256 |
| Relapsed | 2 | 11 | 29.11 ± 4.92 | Not significant (p > 0.05) | 8.76 ± 1.08 | 0.0708 |
Values are mean ± S.E.M.